Boston Scientific Corporation
DE ˙ XTRA ˙ FR0010424135
41,05 € ↓ -0,25 (-0,61%)
2026-06-04
AKTIENPREIS
SecurityDE:BSX / Boston Scientific Corporation
InstitutionV-Square Quantitative Management LLC
Latest Disclosed Ownership9,377 shares
Latest Disclosed Value $ 588,407
V-Square Quantitative Management LLC reports 12.99% increase in ownership of BSX / Boston Scientific Corporation

On April 27, 2026 - V-Square Quantitative Management LLC filed a 13F-HR form disclosing ownership of 9,377 shares of Boston Scientific Corporation (DE:BSX) valued at $504,483 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 8,299 shares of Boston Scientific Corporation. This represents a change in shares of 12.99% during the quarter. The current value of the position is $384,926 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F Boston Scientific A 101137107 9,377 1,078 12.99 588 -25.66 0.0622
2026-01-22 2025-12-31 13F Boston Scientific A 101137107 8,299 -4,840 -36.84 791 -38.30 0.0823
2025-11-12 2025-09-30 13F Boston Scientific A 101137107 13,139 -39 -0.30 1,283 -9.40 0.2164
2025-07-17 2025-06-30 13F Boston Scientific A 101137107 13,178 2,389 22.14 1,415 30.06 0.1895
2025-05-13 2025-03-31 13F Boston Scientific A 101137107 10,789 56 0.52 1,088 13.57 0.1589
2025-01-30 2024-12-31 13F Boston Scientific A 101137107 10,733 -400 -3.59 959 2.79 0.1359
2024-10-17 2024-09-30 13F Boston Scientific A 101137107 11,133 1,914 20.76 933 31.45 0.1370
2024-07-16 2024-06-30 13F Boston Scientific A 101137107 9,219 -569 -5.81 710 5.82 0.1151
2024-04-24 2024-03-31 13F Boston Scientific A 101137107 9,788 5,950 155.03 670 203.17 0.0938
2024-02-21 2023-12-31 13F Boston Scientific A 101137107 3,838 0 0.00 222 9.41 0.0392
2023-11-13 2023-09-30 13F Boston Scientific A 101137107 3,838 3,639 1,828.64 203 1,920.00 0.0892
2023-07-26 2023-06-30 13F Boston Scientific A 101137107 199 199 11 0.0079
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.